Balasa Dinverno & Foltz’s Omega Healthcare OHI Stock Holding History

Balasa Dinverno & Foltz’s Portfolio OHI Stock Details OHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-10,235	Closed	-$390K	–	258
2019 Q1	$390K	Buy	+10,235	New	+$380K	0.05%	158

Other funds holding OHI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Balasa Dinverno & Foltz's OHI Position: Q2 2019 in Review

Balasa Dinverno & Foltz sold out of Omega Healthcare (OHI) in Q2 2019, closing a stake of 10,235 shares — an estimated $390K sold.

Balasa Dinverno & Foltz first reported a position in OHI in Q1 2019 and held it in 1 quarter. The position peaked at $390K in Q1 2019. 466 funds tracked by Wall St. Rank hold OHI as of Q2 2019.

Balasa Dinverno & Foltz reported no remaining Omega Healthcare position as of Q2 2019 after selling out during the quarter.
Balasa Dinverno & Foltz sold 10,235 Omega Healthcare shares in Q2 2019, an estimated $390K.
Balasa Dinverno & Foltz first reported a position in Omega Healthcare in Q1 2019 and held it in 1 quarter.
Balasa Dinverno & Foltz's Omega Healthcare position peaked at $390K in Q1 2019.
466 funds tracked by Wall St. Rank held Omega Healthcare as of Q2 2019.

Based on Balasa Dinverno & Foltz's 13F filing for Q2 2019, filed 7 Aug 2019.